Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Total Current Liabilities

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Current Liabilities ₹5,664 Cr₹2,120 Cr₹1,863 Cr₹2,623 Cr₹1,353 Cr

What is the latest Total Current Liabilities ratio of MANKIND PHARMA ?

The latest Total Current Liabilities ratio of MANKIND PHARMA is ₹5,664 Cr based on Mar2025 Consolidated results.
Year Total Current Liabilities
Mar2025₹5,664 Cr
Mar2024₹2,120 Cr
Mar2023₹1,863 Cr
Mar2022₹2,623 Cr
Mar2021₹1,353 Cr

How is Total Current Liabilities of MANKIND PHARMA Trending?

Years Total Current Liabilities % Change
Mar2025 ₹5,664 Cr
167.18
Mar2024 ₹2,120 Cr
13.77
Mar2023 ₹1,863 Cr
-28.98
Mar2022 ₹2,623 Cr
93.84
Mar2021 ₹1,353 Cr -

Compare Total Current Liabilities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹101,633.1 Cr 1.8% 1.8% 6.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,792.0 Cr 1.4% 1.2% 13.8% Stock Analytics
DIVIS LABORATORIES ₹178,152.0 Cr -0.5% -0.6% 4% Stock Analytics
TORRENT PHARMACEUTICALS ₹152,915.0 Cr 2.1% 1.5% 42.2% Stock Analytics
CIPLA ₹116,354.0 Cr 6.4% 1.6% -3.1% Stock Analytics
DR REDDYS LABORATORIES ₹112,681.0 Cr 6.2% 1.6% 0.2% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

1.8%

1.8%

6.6%

SENSEX

-0.4%

0.8%

-5.3%


You may also like the below Video Courses